Research ArticleClinical Studies
Association Between PD-L1 Expression and Efficacy of Chemoimmunotherapy in Extensive-stage Small Cell Lung Cancer
KENJIRO TSURUOKA, YOSUKE TAMURA, YASUYUKI SHIMAZU, MASAHIRO ARAI, SHO MITSUYA, TOMOYA FUNAMOTO, HIROYUKI TSUJI, NINSO MATSUNAGA, TAKAHIKO NAKAMURA, SOICHIRO IKEDA, SHIGERU KAWABATA, AKIHISA IMAGAWA and YASUHITO FUJISAKA
Anticancer Research December 2024, 44 (12) 5531-5539; DOI: https://doi.org/10.21873/anticanres.17379
KENJIRO TSURUOKA
1Department of Internal Medicine (I), Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan;
YOSUKE TAMURA
1Department of Internal Medicine (I), Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan;
YASUYUKI SHIMAZU
1Department of Internal Medicine (I), Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan;
MASAHIRO ARAI
1Department of Internal Medicine (I), Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan;
SHO MITSUYA
1Department of Internal Medicine (I), Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan;
TOMOYA FUNAMOTO
1Department of Internal Medicine (I), Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan;
HIROYUKI TSUJI
2Department of Clinical Research Center, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan;
NINSO MATSUNAGA
1Department of Internal Medicine (I), Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan;
TAKAHIKO NAKAMURA
1Department of Internal Medicine (I), Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan;
SOICHIRO IKEDA
1Department of Internal Medicine (I), Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan;
SHIGERU KAWABATA
3Department of Pathology, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan;
AKIHISA IMAGAWA
1Department of Internal Medicine (I), Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan;
YASUHITO FUJISAKA
4Department of Medical Oncology, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Association Between PD-L1 Expression and Efficacy of Chemoimmunotherapy in Extensive-stage Small Cell Lung Cancer
KENJIRO TSURUOKA, YOSUKE TAMURA, YASUYUKI SHIMAZU, MASAHIRO ARAI, SHO MITSUYA, TOMOYA FUNAMOTO, HIROYUKI TSUJI, NINSO MATSUNAGA, TAKAHIKO NAKAMURA, SOICHIRO IKEDA, SHIGERU KAWABATA, AKIHISA IMAGAWA, YASUHITO FUJISAKA
Anticancer Research Dec 2024, 44 (12) 5531-5539; DOI: 10.21873/anticanres.17379
Association Between PD-L1 Expression and Efficacy of Chemoimmunotherapy in Extensive-stage Small Cell Lung Cancer
KENJIRO TSURUOKA, YOSUKE TAMURA, YASUYUKI SHIMAZU, MASAHIRO ARAI, SHO MITSUYA, TOMOYA FUNAMOTO, HIROYUKI TSUJI, NINSO MATSUNAGA, TAKAHIKO NAKAMURA, SOICHIRO IKEDA, SHIGERU KAWABATA, AKIHISA IMAGAWA, YASUHITO FUJISAKA
Anticancer Research Dec 2024, 44 (12) 5531-5539; DOI: 10.21873/anticanres.17379
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.